Post-marketing safety of anakinra and canakinumab: a real-world pharmacovigilance study based on FDA adverse event reporting system

Hao Liu(Shandong University of Traditional Chinese Medicine), Di Luo(Shandong University of Traditional Chinese Medicine), Dezhi Yan(Shandong University of Traditional Chinese Medicine), Wei Yan(Shandong University of Traditional Chinese Medicine), Jinsong Li(ShanghaiTech University)
Frontiers in Pharmacology
April 30, 2025
Cited by 7


Related Papers